International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7927767
Original Article
Fetal Head Station in Active Phase of Labour in Nullipara: Study at a Tertiary Care Centre
 ,
 ,
 ,
Published
May 12, 2023
Abstract
Objective: To study the course and duration of labor, mode of delivery, fetomaternal outcome in relation to station of fetal head in active phase in a nullipara. Study design: A Prospective observational study was conducted in the department of Obstetrics and Gynaecology for a period of 2 years in Government Medical College, Aurangabad. This study was done on 100 nullipara women at 37 completed weeks to 41 completed weeks of gestation who delivered in our institute. Results: In our study, 56% cases were at age group of 21-25 years. Maximum cases i.e. 41% presented at 39.1-40wks of gestation age. The mean duration of labour was found to be more with higher stations. Need for LSCS increased with higher station. The mean birth weights were found to be more with higher fetal head stations. The rate was NICU admission was 9%. Conclusion: A nullipara with unengaged fetal head and high station can be given successful trial of normal vaginal delivery under constant vigilance and timely intervention if required.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2123 Views
326 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved